HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Adds Cortaid, Insight Gets Bonine In Pfizer/Pharmacia Pre-Merger Sell Off

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson will add Pharmacia's Cortaid OTC anti-itch and rash line to its skin remedies business in one of several divestitures planned to resolve Federal Trade Commission concerns regarding potential monopolies resulting from the merger of Pharmacia and Pfizer

You may also be interested in...



J&J/McNeil Divests E.P.T. Pregnancy Tests To Insight Pharmaceuticals

Johnson & Johnson divests another non-core consumer health brand – e.p.t. pregnancy tests – as the remediation of its OTC business continues.

Chattem Considering OTC Cough/Cold, GI Tract Purchases, Exec Says

Chattem is eyeing the OTC cough/cold and gastrointestinal tract categories as possible areas for expansion through acquisition, President & Chief Operating Officer Alec Taylor said at a BB&T Capital Markets Equity Research Conference in Leesburg, Va. May 21

Pfizer Expanding New York, New Jersey Facilities With $800 Mil. Investments

Pfizer will expand its Consumer Healthcare facilities in Morris Plains, N.J. by adding 900,000 square feet over the next five years, the company said in a 1May 2 statement

Related Content

Topics

UsernamePublicRestriction

Register

RS129656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel